Concepedia

Warner B. Bair

WB

Statistics

Publications

9

Citations

676

H-Index

9

Active since

1999

Affiliations

University of Arizona(Current)

Institute of Pharmacology

Warner B. Bair is an author at University of Arizona specializing in medicine, oncology, and pharmacology.

Publications per year

1999–2011

9

Publications

9

The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth

Christopher M. Cabello, Warner B. Bair, Sarah D. Lamore et al. · Free Radical Biology and Medicine · 2008 · 209 citations

Medicine, Cancer Biology, Oncology +10

Experimental therapeutics: targeting the redox Achilles heel of cancer.

Christopher M. Cabello, Warner B. Bair, Georg T. Wondrak · PubMed · 2007 · 110 citations

Life Sciences, Oncology, Pharmacology +17

GLO1 overexpression in human malignant melanoma

Warner B. Bair, Christopher M. Cabello, Kôji Uchida et al. · Melanoma Research · 2010 · 93 citations · Full text

Medicine, Molecular Biology, Oncology +17

The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis

Christopher M. Cabello, Sarah D. Lamore, Warner B. Bair et al. · Investigational New Drugs · 2011 · 81 citations · Full text

Medicine, Oncology, Pharmacology +14

The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A (p21) upregulation in human cancer cell lines

Christopher M. Cabello, Warner B. Bair, Stephanie Ley et al. · Biochemical Pharmacology · 2009 · 61 citations · Full text

Medicine, Cell Biology, Oncology +17

1–5 of 9